Harel Insurance Investments & Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $120K | Sell |
5,000
-19,000
| -79% | -$497K | ﹤0.01% | 386 |
|
|
2026
Q1 | $674K | Buy |
+24,000
| New | +$639K | ﹤0.01% | 189 |
|
|
2025
Q2 | – | Sell |
-8,800
| Closed | -$223K | – | 481 |
|
|
2025
Q1 | $223K | Buy |
+8,800
| New | +$230K | ﹤0.01% | 267 |
|
|
2024
Q3 | – | Sell |
-2,203
| Closed | -$61K | – | 557 |
|
|
2024
Q2 | $61K | Sell |
2,203
-7,500
| -77% | -$206K | ﹤0.01% | 358 |
|
|
2024
Q1 | $269K | Sell |
9,703
-43,496
| -82% | -$1.21M | 0.01% | 226 |
|
|
2023
Q4 | $1.53M | Sell |
53,199
-21,260
| -29% | -$643K | 0.03% | 151 |
|
|
2023
Q3 | $2.44M | Buy |
74,459
+5,939
| +9% | +$210K | 0.05% | 119 |
|
|
2023
Q2 | $2.48M | Buy |
68,520
+28,734
| +72% | +$1.12M | 0.06% | 86 |
|
|
2023
Q1 | $1.61M | Sell |
39,786
-6,293
| -14% | -$272K | 0.03% | 141 |
|
|
2022
Q4 | $2.36M | Sell |
46,079
-242,816
| -84% | -$11.6M | 0.05% | 121 |
|
|
2022
Q3 | $12.7M | Buy |
288,895
+9,883
| +4% | +$480K | 0.31% | 63 |
|
|
2022
Q2 | $14.6M | Buy |
279,012
+2,191
| +0.8% | +$112K | 0.31% | 66 |
|
|
2022
Q1 | $14.3M | Sell |
276,821
-36,724
| -12% | -$1.91M | 0.23% | 79 |
|
|
2021
Q4 | $18.5M | Buy |
313,545
+273,611
| +685% | +$13.6M | 0.35% | 57 |
|
|
2021
Q3 | $1.72M | Buy |
39,934
+3,031
| +8% | +$134K | 0.04% | 103 |
|
|
2021
Q2 | $4.67M | Sell |
36,903
-8,346
| -18% | -$325K | 0.1% | 95 |
|
|
2021
Q1 | $5.43M | Buy |
45,249
+5,928
| +15% | +$210K | 0.1% | 121 |
|
|
2020
Q4 | $4.66M | Sell |
39,321
-1,304
| -3% | -$47.8K | 0.11% | 92 |
|
|
2020
Q3 | $1.42M | Buy |
40,625
+26,697
| +192% | +$936K | 0.05% | 92 |
|
|
2020
Q2 | $432K | Buy |
13,928
+2,804
| +25% | +$95.3K | 0.01% | 143 |
|
|
2020
Q1 | $344K | Buy |
11,124
+4,091
| +58% | +$139K | 0.02% | 127 |
|
|
2019
Q4 | $261K | Buy |
+7,033
| New | +$251K | 0.01% | 178 |
|
|
2019
Q3 | – | Sell |
-20,237
| Closed | -$832K | – | 549 |
|
|
2019
Q2 | $832K | Buy |
20,237
+4,427
| +28% | +$176K | 0.04% | 80 |
|
|
2019
Q1 | $637K | Sell |
15,810
-11,278
| -42% | -$452K | 0.04% | 75 |
|
|
2018
Q4 | $1.12M | Buy |
27,088
+10,540
| +64% | +$438K | 0.07% | 81 |
|
|
2018
Q3 | $692K | Sell |
16,548
-1,054
| -6% | -$40.6K | 0.03% | 125 |
|
|
2018
Q2 | $606K | Sell |
17,602
-232,059
| -93% | -$7.93M | 0.03% | 117 |
|
|
2018
Q1 | $8.41M | Buy |
249,661
+949
| +0.4% | +$32.6K | 0.47% | 46 |
|
|
2017
Q4 | $8.55M | Buy |
248,712
+613
| +0.2% | +$20.9K | 0.54% | 41 |
|
|
2017
Q3 | $8.4M | Hold |
248,099
| – | – | 0.69% | 33 |
|
|
2017
Q2 | $7.91M | Sell |
248,099
-1,586
| -0.6% | -$50K | 0.64% | 34 |
|
|
2017
Q1 | $8.1M | Buy |
249,685
+16,572
| +7% | +$522K | 0.71% | 34 |
|
|
2016
Q4 | $7.49M | Hold |
233,113
| – | – | 1.06% | 24 |
|
|
2016
Q3 | $7.49M | Sell |
233,113
-11,626
| -5% | -$389K | 1.01% | 25 |
|
|
2016
Q2 | $8.18M | Buy |
244,739
+11,626
| +5% | +$371K | 0.98% | 26 |
|
|
2016
Q1 | $6.55M | Hold |
233,113
| – | – | 0.78% | 29 |
|
|
2015
Q4 | $7.14M | Buy |
+233,113
| New | +$7.33M | 0.83% | 27 |
|
Other funds holding PFE
Harel Insurance Investments & Financial Services's PFE Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services reduced its Pfizer (PFE) stake by 79% in Q2 2026, selling an estimated $497K and leaving 5,000 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #386.
Harel Insurance Investments & Financial Services first reported a position in PFE in Q4 2015 and has held it in 37 quarters since. The position peaked at $18.5M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Harel Insurance Investments & Financial Services held 5,000 shares of Pfizer worth $120K as of Q2 2026.
- Harel Insurance Investments & Financial Services sold 19,000 Pfizer shares in Q2 2026, an estimated $497K.
- Pfizer made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #386 holding.
- Harel Insurance Investments & Financial Services first reported a position in Pfizer in Q4 2015 and has held it in 37 quarters since.
- Harel Insurance Investments & Financial Services's Pfizer position peaked at $18.5M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.